Dimitra Vasdeki

ORCID: 0000-0003-0481-344X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Hepatitis Viruses Studies and Epidemiology
  • Health Systems, Economic Evaluations, Quality of Life
  • Blood Pressure and Hypertension Studies
  • Liver Disease Diagnosis and Treatment
  • Heart Failure Treatment and Management
  • Vaccine Coverage and Hesitancy
  • Alcohol Consumption and Health Effects
  • Vitamin D Research Studies
  • Hepatitis C virus research
  • Vitamin C and Antioxidants Research
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Health and Mental Health
  • COVID-19 Impact on Reproduction
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pregnancy and preeclampsia studies
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Peripheral Artery Disease Management
  • Frailty in Older Adults
  • Birth, Development, and Health
  • Dialysis and Renal Disease Management
  • Cardiovascular and exercise physiology

Aristotle University of Thessaloniki
2017-2025

AHEPA University Hospital
2017-2025

We aimed to assess the impact of an educational, motivational intervention on adherence oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation (AF).Hospitalized AF who received OAC were randomly assigned usual medical care or a proactive intervention, comprising interviewing, and tailored counselling medication adherence. The primary study outcome was at 1 year, which evaluated according proportion days covered (PDC) by regimens assessed through nationwide registers...

10.1093/ehjcvp/pvaa039 article EN European Heart Journal - Cardiovascular Pharmacotherapy 2020-04-21

Vaccination against various pathogens is recommended for HIV positive adults. There are not sufficient data either on vaccination coverage of adults or the risk factors associated with poor adherence to routine vaccination.During period 2004-2014 a group infected hepatitis A virus (HAV), B (HBV), seasonal influenza and pneumococcal disease was recorded. separated into two chronological periods, before after 2010, as 2010 marks start economic crisis in Greece.1210 patients were included our...

10.1080/21645515.2018.1509644 article EN Human Vaccines & Immunotherapeutics 2018-08-15

This study sought to develop and validate a risk score predict mortality in patients with atrial fibrillation (AF) after hospitalization for cardiac reasons. The new was derived from prospective cohort of hospitalized concurrent AF. outcome measures were all-cause cardiovascular mortality. Random forest used variable selection. A points model predictor variables developed by weighted Cox regression coefficients internally validated bootstrapping. In total, 1130 AF included. During median...

10.1016/j.hjc.2021.01.007 article EN cc-by Hellenic Journal of Cardiology 2021-01-29

Background: Proper anticoagulation is a crucial therapeutic regimen in atrial fibrillation (AF). Objectives: To evaluate the real-life prescriptions of AF patients upon hospital discharge. Methods: We studied 768 with comorbid who were discharged from cardiology ward tertiary hospital. assessed appropriateness oral (OAC) regimens at discharge based on stroke risk (CHA 2 DS -Vasc score), SAMe-TT R (sex, age, medical history, treatment, tobacco, race) score for vitamin K antagonists (VKA), and...

10.1177/1074248418821712 article EN Journal of Cardiovascular Pharmacology and Therapeutics 2019-01-01

Percutaneous left atrial appendage occlusion (LAAO) is an alternative nonpharmacological therapeutic option for stroke prevention in patients with NVAF. However, no data exist on potential LAAO candidates' prevalence among 'real-world' NVAF patients. This study aimed to investigate the indications hospitalized comorbid nonvalvular fibrillation (NVAF).This a post-hoc analysis of MISOAC-AF (Motivational Interviewing Support OAC-AF, ClinicalTrials.gov: NCT02941978), randomized controlled trial,...

10.2459/jcm.0000000000001226 article EN Journal of Cardiovascular Medicine 2021-09-27

Abstract Background Oral anticoagulation (OAC) is paramount to effective thromboprophylaxis; yet adherence OAC remains largely suboptimal in patients with atrial fibrillation (AF). Purpose We aimed assess the impact of an educational, motivational intervention on non-valvular AF. Methods Hospitalised AF who received were randomly assigned usual medical care or a proactive intervention, comprising interviewing and tailored counseling medication adherence. The primary study outcome was at...

10.1093/ehjci/ehaa946.0641 article EN European Heart Journal 2020-11-01

Abstract Background Prior risk stratification schemes for atrial fibrillation (AF) have extensively focused on stroke as the principal outcome. However, an accurate estimation of death in patients with AF has received disproportional attention. Purpose The aim this study was to develop and validate a score predicting mortality who underwent hospitalization cardiac reasons. Methods new developed internally validated 887 AF, were followed up median 2 years. outcome measure all-cause mortality....

10.1093/eurheartj/ehz748.0619 article EN European Heart Journal 2019-10-01
Coming Soon ...